Penserra Capital Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-28,284
| Closed | -$89K | – | 1235 |
|
|
2023
Q3 | $89K | Buy |
28,284
+7,109
| +34% | +$22.4K | ﹤0.01% | 914 |
|
|
2023
Q2 | $105K | Buy |
21,175
+3,065
| +17% | +$15.2K | ﹤0.01% | 928 |
|
|
2023
Q1 | $89K | Buy |
18,110
+4,890
| +37% | +$24K | ﹤0.01% | 783 |
|
|
2022
Q4 | $83K | Sell |
13,220
-4,052
| -23% | -$25.4K | ﹤0.01% | 831 |
|
|
2022
Q3 | $186K | Buy |
17,272
+11,732
| +212% | +$126K | 0.01% | 652 |
|
|
2022
Q2 | $63K | Sell |
5,540
-1,736
| -24% | -$19.7K | ﹤0.01% | 857 |
|
|
2022
Q1 | $66K | Buy |
+7,276
| New | +$66K | ﹤0.01% | 939 |
|
|
2021
Q4 | – | Sell |
-3,255
| Closed | -$83K | – | 1355 |
|
|
2021
Q3 | $83K | Buy |
3,255
+35
| +1% | +$892 | ﹤0.01% | 869 |
|
|
2021
Q2 | $83K | Buy |
3,220
+40
| +1% | +$1.03K | ﹤0.01% | 849 |
|
|
2021
Q1 | $112K | Sell |
3,180
-60
| -2% | -$2.11K | ﹤0.01% | 669 |
|
|
2020
Q4 | $81K | Buy |
3,240
+2,052
| +173% | +$51.3K | ﹤0.01% | 617 |
|
|
2020
Q3 | $44K | Buy |
+1,188
| New | +$44K | ﹤0.01% | 640 |
|